Genelux (GNLX) Gains from Sales and Divestitures (2023 - 2025)
Genelux has reported Gains from Sales and Divestitures over the past 3 years, most recently at $314042.0 for Q4 2025.
- Quarterly results put Gains from Sales and Divestitures at $314042.0 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $314042.0 (changed N/A YoY), and the annual figure for FY2025 was $314042.0, changed.
- Gains from Sales and Divestitures for Q4 2025 was $314042.0 at Genelux, up from $287762.0 in the prior quarter.
- Over the last five years, Gains from Sales and Divestitures for GNLX hit a ceiling of $314042.0 in Q4 2025 and a floor of $1250.0 in Q2 2025.
- Median Gains from Sales and Divestitures over the past 3 years was $131267.0 (2024), compared with a mean of $156174.8.
- Peak annual rise in Gains from Sales and Divestitures hit 83.51% in 2025, while the deepest fall reached 99.05% in 2025.
- Genelux's Gains from Sales and Divestitures stood at $113500.0 in 2023, then skyrocketed by 38.16% to $156810.0 in 2024, then soared by 100.27% to $314042.0 in 2025.
- The last three reported values for Gains from Sales and Divestitures were $314042.0 (Q4 2025), $287762.0 (Q3 2025), and $1250.0 (Q2 2025) per Business Quant data.